Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: Role of bioactive TNF and Th1 type cytokines

Cytokine

Volumn 44, Issue 1, 2008, Pages 118-125

  Olleros, Maria L ^a   Martin, Maria L ^a   Vesin, Dominique ^a   Fotio, Agathe L ^a   Santiago Raber, Marie Laure ^a   Rubbia Brandt, Laura ^b   Spahr, Laurent ^c   Hadengue, Antoine ^c   Garcia, Irene ^a  

^a Centre Médical Universitaire   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Endotoxin; Steatohepatitis; Th1 type cytokines; TNF; TNF receptors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; ENDOTOXIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; LIPID DIET; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEATOHEPATITIS; TH1 CELL;

ANIMALS; CYTOKINES; DIETARY FATS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ETHANOL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; RNA, MESSENGER; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 52949133396     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.07.001     Document Type: Article

References (41)

1. Nagy L.E. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med 228 (2003) 882-890
2. Spahr L., and Hadengue A. Alcoholic liver disease; natural history, diagnosis, clinical features, evaluation, prognosis and management. In: Rodes J., Benhamou J.P., Blei A., Reichen J., and Rizzeto M. (Eds). Textbook of Hepatology; From Basic Science to Clinical Practice vol. 2 (2007), Blackwell Publishing, Oxford 1157-1178
3. Tilg H., and Diehl A.M. Cytokines in alcoholic and non alcoholic steatohepatitis. N Engl J Med 343 (2000) 1467-1476
4. McClain C.J., Barve S., Barve S., Deaciuc I., and Hill D.B. Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 22 (1998) 248S-252S
5. McClain C.J., and Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9 (1989) 349-351
6. Honchel R., Ray M.B., Marsano L., Cohen D., Lee E., Shedlofsky S., et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 16 (1992) 665-669
7. Diez-Ruiz A., Tilz G.P., Gutierrez-Gea F., Gil-Extremera B., Murr C., Wachter H., et al. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology 21 (1995) 976-978
8. Naveau S., Emilie D., Balian A., Grangeot-Keros L., Borotto E., Portier A., et al. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity. J Hepatol 28 (1998) 778-784
9. von Baehr V., Döcke W.-D., Plauth M., Liebenthal C., Küpferling S., Lochs H., et al. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 47 (2000) 281-287
10. Spahr L., Giostra E., Frossard J.L., Bresson-Hadni S., Rubbia-Brandt L., and Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 41 (2004) 229-234
11. Spahr L., Rubbia-Brandt L., Frossard J.L., Giostra E., Rougemont A.L., Pugin J., et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 37 (2002) 448-455
12. Naveau S., Chollet-Martin S., Dharancy S., Mathurin P., Jouet P., Piquet M.A., et al. Foie-Alcool group of the Association Francaise pour l'Etude du Foie. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 39 (2004) 1390-1397
13. Gustot T., Lemmers A., Moreno C., Nagy N., Quertinmont E., Nicaise C., et al. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43 (2006) 989-1000
14. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007) 1761-1772
15. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Wheeler M.D., Gäbele E., et al. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 168 (2002) 2963-2969
16. Nanji A.A., Zhao S., Sadrzadeh S.M., and Waxman D.J. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19 (1994) 1483-1487
17. Limuro Y., Gallucci R.M., Luster M.I.H., and Thurman R.G. Antibodies to tumor necrosis factor attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26 (1997) 1530-1537
18. Yin M., Wheeler M.D., Kono H., Bradford B.U., Gallucci R.M., Luster M.I., et al. Essential role of tumor necrosis factor a in alcohol-induced liver injury in mice. Gastroenterology 117 (1999) 942-950
19. Francés R., Chiva M., Sánchez E., González-Navajas J.M., Llovet T., Zapater P., et al. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 46 (2007) 797-803
20. Lieber C.S., DeCarli L.M., and Sorell M.F. Experimental methods of ethanol administration. Hepatology 10 (1989) 501-510
21. Koteish A., Yang S., Lin H., Huang X., and Diehl A.M. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 277 (2002) 13037-13044
22. Garcia I., Miyazaki Y., Araki K., Araki M., Lucas R., Grau G.E., et al. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol 25 (1995) 2401-2407
23. Guler R., Olleros M.L., Vesin D., Parapanov R., Vesin C., Kantengwa S., et al. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol 41 (2004) 773-781
24. Promrat K., Lutchman G., Uwaifo G.I., Freedman R.J., Soza A., Heller T., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39 (2004) 188-196
25. Bergmeyer H.U., Horder M., and Rej R. IFCC method for aspartate aminotransferase. J Clin Chem Clin Biochem 24 (1986) 497-510
26. Garcia I., Guler R., Vesin D., Olleros M.L., Vassalli P., Chvatchko Y., et al. Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest 80 (2000) 1385-1397
27. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 245 (1997) 154-160
28. Peirson S.N., Butler J.N., and Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res 31 (2003) e73
29. Olleros M.L., Vesin D., Martinez-Soria E., Allenbach C., Tacchini-Cottier F., Pache J.C., et al. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guerin and Mycobacterium tuberculosis clearance. Immunology 122 (2007) 350-361
30. Day Y.J., Marshall M.A., Huang L., McDuffie M.J., Okusa M.D., and Linden J. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 286 (2004) G285-G293
31. Koerber K., Sass G., Kiemer A.K., Vollmar A.M., and Tiegs G. In vivo regulation of inducible NO synthase in immune-mediated liver injury in mice. Hepatology 36 (2002) 1061-1069
32. Saas G., Heinlein S., Agli A., Bang R., Schümann J., and Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19 (2002) 115-120
33. Drapier J.C., Wietzerbin J., and Hibbs J.B. Interferon-gamma and tumor necrosis factor induce the l-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18 (1988) 1587-1592
34. Solomon K.A., Pesti N., Wu G., and Newton R.C. Cutting edge: a dominant negative form of TNF-α converting enzyme inhibits ProTNF and TNFRII secretion. J Immunol 163 (1999) 4105-4108
35. Vonlaufen A., Xu Z., Daniel B., Kumar R.K., Pirola R., Wilson J., et al. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. Gastroenterology 133 (2007) 1293-1303
36. Poniachik J., Csendes A., Díaz J.C., Rojas J., Burdiles P., Maluenda F., et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 33 (2006) 252-257
37. Hill D.B., Marsano L., Cohen D., Allen J., Shedlofsky S., and McClain C.J. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119 (1992) 547-552
38. Kamimura S., and Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22 (1995) 1304-1309
39. Kremer M., Hines I.N., Milton R.J., and Wheeler M.D. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 44 (2006) 216-227
40. Nanji A.A., Greenberg S.S., Tahan S.R., Fogt F., Loscalzo J., Sadrzadeh S.M., et al. Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology 109 (1995) 899-907
41. McKim S.E., Gäbele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., et al. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125 (2003) 1834-1844